Evotec confirm closing of transaction with Sanofi to accelerate infectious disease research and development

Hamburg, Germany, 03 Jul 2018

Evotec AG today announced that the strategic transaction signed on 15 June 2018, to integrate Sanofi’s infectious disease unit including licensing-in the majority of Sanofi’s infectious disease research portfolio, has been successfully closed with effect from 01 July 2018.